These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1403 related items for PubMed ID: 9436955

  • 1. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ, Birmingham MC, Paladino JA, Carr JR, Hyatt JM, Forrest A, Zimmer GS, Adelman MH, Cumbo TJ.
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
    Schentag JJ.
    J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS, Paladino JA, Schentag JJ.
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of severe infections: should one always administer an aminoglycoside?].
    Cometta A, Baumgartner JD.
    Schweiz Med Wochenschr Suppl; 1996 Apr; 76():28S-33S. PubMed ID: 8677416
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.
    Drusano GL, Preston SL, Fowler C, Corrado M, Weisinger B, Kahn J.
    J Infect Dis; 2004 May 01; 189(9):1590-7. PubMed ID: 15116294
    [Abstract] [Full Text] [Related]

  • 12. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP.
    Semin Respir Infect; 1993 Dec 01; 8(4):268-84. PubMed ID: 7938924
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N.
    Dan Med Bull; 1988 Oct 01; 35(5):422-37. PubMed ID: 3066588
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models.
    Schentag JJ.
    Clin Infect Dis; 2000 Aug 01; 31 Suppl 2():S40-4. PubMed ID: 10984327
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.
    Cazzola M, Matera MG, Noschese P.
    Pulm Pharmacol Ther; 2000 Aug 01; 13(6):249-56. PubMed ID: 11061979
    [Abstract] [Full Text] [Related]

  • 19. Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia.
    Scaglione F, Esposito S, Leone S, Lucini V, Pannacci M, Ma L, Drusano GL.
    Eur Respir J; 2009 Aug 01; 34(2):394-400. PubMed ID: 19213786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.